Corporativo Neomedica is a leading Mexican distributor of medical devices and specialzied supplies, with more than 30 years of experience serving public and provate hospitals, physicians, and specialized distributors nationwide.

If offers surgical instruments, wound care, leparoscopic equipment, among other similar products. In 2025, the Company reported revenues of USD 11.7 million and an EBITDA margin of 19.6%, reflecting solid profitability and operational eficiency.

Oaklins Mexico’s role in the transaction

ZIMMA acted as the exclusive sell-side advisor to the shareholders of Neomedica on the sale of a majority stake to Ascendis Capital.

The transaction highlights Oaklins’ experience in the healthcare sector and reinforces its strong track record advising mid-market companies through international competitive processes.

Results

The transaction represents a significant milestone for the company, as its partnership with Ascendis Capital supports Neomedica’s objective of a majority interest exit and is expected to drive accelerated growth, supporting the company’s continued expansion in other therapeutic verticals.